131 related articles for article (PubMed ID: 15478462)
21. Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A.
Aguilera JJ; Zhang F; Beaudet JM; Linhardt RJ; Colón W
Biochimie; 2014 Sep; 104():70-80. PubMed ID: 24878279
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the oligomerization and aggregation of human Serum Amyloid A.
Patke S; Srinivasan S; Maheshwari R; Srivastava SK; Aguilera JJ; Colón W; Kane RS
PLoS One; 2013; 8(6):e64974. PubMed ID: 23750222
[TBL] [Abstract][Full Text] [Related]
23. Complete primary structures of two major murine serum amyloid A proteins deduced from cDNA sequences.
Yamamoto K; Migita S
Proc Natl Acad Sci U S A; 1985 May; 82(9):2915-9. PubMed ID: 3857624
[TBL] [Abstract][Full Text] [Related]
24. From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature.
Wang L; Lashuel HA; Colón W
Amyloid; 2005 Sep; 12(3):139-48. PubMed ID: 16194868
[TBL] [Abstract][Full Text] [Related]
25. Interaction of serum amyloid A with human cystatin C--identification of binding sites.
Spodzieja M; Szymańska A; Kołodziejczyk A; Prądzińska M; Maszota M; Stefanowicz P; Szewczuk Z; Grubb A; Czaplewska P
J Mol Recognit; 2012 Oct; 25(10):513-24. PubMed ID: 22996594
[TBL] [Abstract][Full Text] [Related]
26. Structural requirements of glycosaminoglycans for facilitating amyloid fibril formation of human serum amyloid A.
Takase H; Tanaka M; Yamamoto A; Watanabe S; Takahashi S; Nadanaka S; Kitagawa H; Yamada T; Mukai T
Amyloid; 2016 Jun; 23(2):67-75. PubMed ID: 27097047
[TBL] [Abstract][Full Text] [Related]
27. Identification of two novel amyloid A protein subsets coexisting in an individual patient of AA-amyloidosis.
Baba S; Takahashi T; Kasama T; Shirasawa H
Biochim Biophys Acta; 1992 Dec; 1180(2):195-200. PubMed ID: 1463770
[TBL] [Abstract][Full Text] [Related]
28. Adenoviral expression of murine serum amyloid A proteins to study amyloid fibrillogenesis.
Kindy MS; King AR; Yu J; Gerardot C; Whitley J; de Beer FC
Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):721-8. PubMed ID: 9620875
[TBL] [Abstract][Full Text] [Related]
29. Rabbit serum amyloid protein A: expression and primary structure deduced from cDNA sequences.
Rygg M; Marhaug G; Husby G; Dowton SB
Scand J Immunol; 1991 Dec; 34(6):727-34. PubMed ID: 1721234
[TBL] [Abstract][Full Text] [Related]
30. Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis.
Jayaraman S; Gantz DL; Haupt C; Gursky O
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6507-E6515. PubMed ID: 28743750
[TBL] [Abstract][Full Text] [Related]
31. Structural prerequisites for serum amyloid A fibril formation.
de Beer MC; de Beer FC; McCubbin WD; Kay CM; Kindy MS
J Biol Chem; 1993 Sep; 268(27):20606-12. PubMed ID: 8376413
[TBL] [Abstract][Full Text] [Related]
32. Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel.
Wang L; Lashuel HA; Walz T; Colon W
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15947-52. PubMed ID: 12456883
[TBL] [Abstract][Full Text] [Related]
33. Circular-dichroism studies on two murine serum amyloid A proteins.
McCubbin WD; Kay CM; Narindrasorasak S; Kisilevsky R
Biochem J; 1988 Dec; 256(3):775-83. PubMed ID: 3223951
[TBL] [Abstract][Full Text] [Related]
34. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
Satheeshkumar KS; Jayakumar R
Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
[TBL] [Abstract][Full Text] [Related]
35. Electrostatic Interactions at N- and C-Termini Determine Fibril Polymorphism in Serum Amyloid A Fragments.
Jannone JM; Grigg JI; Aguirre LM; Jones EM
J Phys Chem B; 2016 Oct; 120(39):10258-10268. PubMed ID: 27632709
[TBL] [Abstract][Full Text] [Related]
36. Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis.
Patel H; Bramall J; Waters H; De Beer MC; Woo P
Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):1041-9. PubMed ID: 8836154
[TBL] [Abstract][Full Text] [Related]
37. Channel formation by serum amyloid A: a potential mechanism for amyloid pathogenesis and host defense.
Hirakura Y; Carreras I; Sipe JD; Kagan BL
Amyloid; 2002 Mar; 9(1):13-23. PubMed ID: 12000193
[TBL] [Abstract][Full Text] [Related]
38. In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice.
Kirschner DA; Elliott-Bryant R; Szumowski KE; Gonnerman WA; Kindy MS; Sipe JD; Cathcart ES
J Struct Biol; 1998 Dec; 124(1):88-98. PubMed ID: 9931277
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the genomic and derived protein structure of a novel human serum amyloid A gene, SAA4.
Watson G; Coade S; Woo P
Scand J Immunol; 1992 Nov; 36(5):703-12. PubMed ID: 1439582
[TBL] [Abstract][Full Text] [Related]
40. Human serum amyloid A. Three hepatic mRNAs and the corresponding proteins in one person.
Kluve-Beckerman B; Dwulet FE; Benson MD
J Clin Invest; 1988 Nov; 82(5):1670-5. PubMed ID: 3183061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
